Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Jasmin Bagge1, Kristine Freude2, Casper Lindegaard3

  • 1Sports Orthopedic Research Center - Copenhagen (SORC-C), Ortopædkirurgisk Afdeling, Københavns Universitetshospital - Hvidovre Hospital.

Ugeskrift for Laeger
|January 18, 2024
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-based therapy injections for the management of knee osteoarthritis: The ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2026
Same author

Comparing participants from a randomized trial and screened non-participants: Implications for generalizability of surgery and exercise therapy in young adults with meniscal tears.

Journal of experimental orthopaedics·2026
Same author

Association between acromial morphology, scapular control, ultrasonographic impingement and non-surgical treatment outcome in patients with isolated subacromial pain syndrome.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2026
Same author

Modeling Synaptic Maturation From Growth Cone to Synapse in Human Organoids.

Journal of neurochemistry·2026
Same author

Randomised three-armed trial investigation of the Copenhagen Achilles tendon Rupture Treatment Algorithm (CARTA) for individualised treatment of acute Achilles tendon rupture.

British journal of sports medicine·2026
Same author

Beyond Return-To-Sport: Mapping ACL Injury History in Currently Active Female Football Players From Youth to Senior Elite Level.

Translational sports medicine·2026
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Mesenchymal stem cell (MSC) therapy for osteoarthritis shows promise. While autologous MSCs are common, allogeneic MSCs face immunological challenges, necessitating careful consideration for treatment decisions.

Area of Science:

  • Regenerative Medicine
  • Immunology
  • Orthopedics

Background:

  • Intraarticular mesenchymal stem cell (MSC) therapy is a promising treatment for osteoarthritis (OA).
  • Autologous MSCs are currently the primary source, but limitations necessitate exploring allogeneic options.
  • Allogeneic MSCs can trigger adverse immunological reactions, including pain, swelling, and cell destruction.

Approach:

  • This review examines the factors influencing the choice between autologous and allogeneic MSC treatments for OA.
  • It highlights the challenges and potential solutions for utilizing allogeneic MSCs in clinical settings.

Key Points:

  • Patient age and cell expansion issues impact autologous MSC viability.
  • Immunological responses to allogeneic MSCs are a significant concern, particularly in early treatments.

Related Experiment Videos

  • The review synthesizes current knowledge to guide therapeutic decisions.

    • Conclusions:

    • Careful consideration of immunological factors is crucial when selecting between autologous and allogeneic MSCs for OA.
    • Further research is needed to mitigate adverse reactions associated with allogeneic MSC therapy.